Alain C. Colige
Liege, WAL 4000, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 61 publications
Reduced RhoGDI2 Expression Disrupts Centrosome Functions and Promotes Mitotic Errors.
Journal: Cells
Published: October 08, 2025
Beyond the stop: Oxadiazole TRIDs restore LRBA protein expression in nonsense-driven primary immunodeficiency.
Journal: Molecular therapy. Nucleic acids
Published: August 12, 2025
Correction: Methylglyoxal, a glycolysis metabolite, triggers metastasis through MEK/ERK/SMAD1 pathway activation in breast cancer.
Journal: Breast cancer research : BCR
Published: June 04, 2025
The ADAMTS2 metalloproteinase inhibits tumor growth by regulating the innate immune system.
Journal: Cancer cell international
Published: March 10, 2025
A precision medicine approach to primary immunodeficiency disease: Ataluren strikes nonsense mutations once again.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: October 14, 2024
Association between PET/CT Scan Findings, Treatment, and Cancer Incidence in a Cohort of AAA Patients.
Journal: Journal of clinical medicine
Published: February 12, 2024
The Dual Function of RhoGDI2 in Immunity and Cancer.
Journal: International journal of molecular sciences
Published: January 31, 2023
Acidosis-induced regulation of adipocyte G0S2 promotes crosstalk between adipocytes and breast cancer cells as well as tumor progression.
Journal: Cancer letters
Published: January 27, 2023
The transcription factor c-Jun inhibits RBM39 to reprogram pre-mRNA splicing during genotoxic stress.
Journal: Nucleic acids research
Published: February 22, 2022
Last Updated: 09/26/2026